Literature DB >> 11502313

Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study.

I J Schatz1, K Masaki, K Yano, R Chen, B L Rodriguez, J D Curb.   

Abstract

BACKGROUND: A generally held belief is that cholesterol concentrations should be kept low to lessen the risk of cardiovascular disease. However, studies of the relation between serum cholesterol and all-cause mortality in elderly people have shown contrasting results. To investigate these discrepancies, we did a longitudinal assessment of changes in both lipid and serum cholesterol concentrations over 20 years, and compared them with mortality.
METHODS: Lipid and serum cholesterol concentrations were measured in 3572 Japanese/American men (aged 71-93 years) as part of the Honolulu Heart Program. We compared changes in these concentrations over 20 years with all-cause mortality using three different Cox proportional hazards models.
FINDINGS: Mean cholesterol fell significantly with increasing age. Age-adjusted mortality rates were 68.3, 48.9, 41.1, and 43.3 for the first to fourth quartiles of cholesterol concentrations, respectively. Relative risks for mortality were 0.72 (95% CI 0.60-0.87), 0.60 (0.49-0.74), and 0.65 (0.53-0.80), in the second, third, and fourth quartiles, respectively, with quartile 1 as reference. A Cox proportional hazard model assessed changes in cholesterol concentrations between examinations three and four. Only the group with low cholesterol concentration at both examinations had a significant association with mortality (risk ratio 1.64, 95% CI 1.13-2.36).
INTERPRETATION: We have been unable to explain our results. These data cast doubt on the scientific justification for lowering cholesterol to very low concentrations (<4.65 mmol/L) in elderly people.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502313     DOI: 10.1016/S0140-6736(01)05553-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  89 in total

1.  Statins as the new aspirin. Conclusions from the heart protection study were premature.

Authors:  Uffe Ravnskov
Journal:  BMJ       Date:  2002-03-30

2.  Risk factor thresholds. Threshold is 37 000 pounds sterling per QALY.

Authors:  Michael A Soljak
Journal:  BMJ       Date:  2002-11-09

3.  Low Alanine Aminotransferase Levels in the Elderly Population: Frailty, Disability, Sarcopenia, and Reduced Survival.

Authors:  Umberto Vespasiani-Gentilucci; Antonio De Vincentis; Luigi Ferrucci; Stefania Bandinelli; Raffaele Antonelli Incalzi; Antonio Picardi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-06-14       Impact factor: 6.053

4.  Drug combinations and all cause mortality in heart disease: use of statins is not supported by study.

Authors:  Eddie Vos
Journal:  BMJ       Date:  2005-07-16

Review 5.  The implications of a growing evidence base for drug use in elderly patients. Part 1. Statins for primary and secondary cardiovascular prevention.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2006-05       Impact factor: 4.335

Review 6.  Management of dyslipidemia: an update.

Authors:  Cynthia A Sanoski
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

7.  Triglycerides Paradox Among the Oldest Old: "The Lower the Better?"

Authors:  Yue-Bin Lv; Chen Mao; Xiang Gao; Zhao-Xue Yin; Virginia Byers Kraus; Jin-Qiu Yuan; Juan Zhang; Jie-Si Luo; Yi Zeng; Xiao-Ming Shi
Journal:  J Am Geriatr Soc       Date:  2019-01-10       Impact factor: 5.562

8.  Serum total cholesterol levels and all-cause mortality in a home-dwelling elderly population: a six-year follow-up.

Authors:  Päivi Tuikkala; Sirpa Hartikainen; Maarit J Korhonen; Piia Lavikainen; Raimo Kettunen; Raimo Sulkava; Hannes Enlund
Journal:  Scand J Prim Health Care       Date:  2010-06       Impact factor: 2.581

Review 9.  Statin therapy in the elderly: does it make good clinical and economic sense?

Authors:  Moira M B Mungall; Allan Gaw; James Shepherd
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Improving mortality prediction using biosocial surveys.

Authors:  Noreen Goldman; Dana A Glei; Yu-Hsuan Lin; Maxine Weinstein
Journal:  Am J Epidemiol       Date:  2009-01-15       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.